RxDoctor Payments Data

Jacqueline Casillas

Pediatric Hematology-Oncology · Los Angeles, CANPI 1790707065

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 48.3% of the total.

$2,866in general payments, 2019–2025

Across 3 payments — averaging $955.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • Partner Therapeutics, Inc.$1K
  • Servier Pharmaceuticals LLC$125
$955,074in research payments, 2019–2025

Across 86 payments — averaging $11,106 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$686K
  • AbbVie$181K
  • Pfizer$39K
  • Incyte Corporation$39K
  • Merck$9K

What the payments were for

  • Consulting fees$1,38448%
  • Speaking & faculty fees$1,35747%
  • Food & beverage$1254%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,866 in reported general payments places this provider in the 65th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California

Other pediatric hematology-oncology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →